U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1987
121
Substance Class Protein
Created
by admin
on Wed Apr 02 01:54:21 GMT 2025
Edited
by admin
on Wed Apr 02 01:54:21 GMT 2025
Protein Type ENZYME INHIBITOR
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
F43I396OIS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Alpha-1-antitrypsin
WHO-DD  
Preferred Name English
.ALPHA.1-PROTEINASE INHIBITOR HUMAN
Common Name English
.ALPHA.-1 PROTEASE INHIBITOR
Common Name English
ALFA1 ANTITRYPSIN
Common Name English
ALPHA-1-PROTEINASE INHIBITOR HUMAN
Common Name English
ALPHA-1-ANTIPROTEINASE
Common Name English
ALPHA-1 PROTEINASE INHIBITOR (HUMAN)
Common Name English
.ALPHA.1-ANTITRYPSIN
MI  
Common Name English
SERPINA1 expressed protein
Common Name English
ARALAST
Brand Name English
ALPHA1-PROTEINASE INHIBITOR (HUMAN)
Common Name English
PROLASTIN-C
Brand Name English
.ALPHA.1-ANTITRYPSIN [MI]
Common Name English
.ALPHA.1-PROTEINASE INHIBITOR HUMAN (PLASMA DERIVED)
Common Name English
GLASSIA
Brand Name English
ALPHA 1-PROTEINASE INHIBITOR (HUMAN)
Common Name English
HUMAN ALPHA1-PROTEINASE INHIBITOR
Common Name English
Serpin A1
Common Name English
ALPHA-1-PROTEINASE INHIBITOR (HUMAN)
Common Name English
Alpha-1-antitrypsin [WHO-DD]
Common Name English
.ALPHA.1-PROTEINASE INHIBITOR (HUMAN)
Common Name English
ALPHA1-PROTEINASE INHIBITOR
Common Name English
ALPHA 1-ANTITRYPSIN
Common Name English
ALPHA1 PROTEINASE INHIBITOR (HUMAN)
Common Name English
ATC-B02AB02
Code English
PROLASTIN
Brand Name English
ALPHA-1-PROTEINASE INHIBITOR,HUMAN [VANDF]
Common Name English
ALPHA-1 PROTEASE INHIBITOR
Common Name English
ZEMAIRA
Brand Name English
ALPHA1-PROTEINASE INHIBITOR [MART.]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 149301
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 190704
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 708519
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
NDF-RT N0000184171
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 272908
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 294309
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 111098
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 283
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
NCI_THESAURUS C307
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 3084
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 576717
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 368112
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 590417
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 190804
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 147601
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 644118
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 448014
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 124299
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
NCI_THESAURUS C308
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 344111
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 203705
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
EU-Orphan Drug EU/3/15/1455
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
WHO-ATC B02AB02
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 256508
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
FDA ORPHAN DRUG 418913
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
232-924-7
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
EVMPD
SUB130886
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
ALTERNATIVE
MERCK INDEX
m1975
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY Merck Index
FDA UNII
F43I396OIS
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
RXCUI
535
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
ALTERNATIVE
NCI_THESAURUS
C82258
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
EVMPD
SUB12796MIG
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
RXCUI
991743
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
CAS
9041-92-3
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
WIKIPEDIA
Alpha-1 antitrypsin
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
SMS_ID
100000156820
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
EPA CompTox
DTXSID2040810
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
DRUG BANK
DB00058
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
DAILYMED
F43I396OIS
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
IUPHAR
7487
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
WIKIPEDIA
ALPHA 1-ANTITRYPSIN
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY
NDF-RT
N0000000197
Created by admin on Wed Apr 02 01:54:21 GMT 2025 , Edited by admin on Wed Apr 02 01:54:21 GMT 2025
PRIMARY Trypsin Inhibitors [MoA]
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_46
N 1_83
N 1_247
Related Record Type Details
Camalprin alfa
DERIVATIVE -> PARENT
Related Record Type Details
.ALPHA.1-PROTEINASE INHIBITOR HUMAN
ACTIVE MOIETY
.ALPHA.1-PROTEINASE INHIBITOR HUMAN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966